Dealmaker’s Diary: A Double Dose of Tickers

By reader request, Alpesh rates a cutting-edge biotech with 232% potential upside and a semiconductor giant with low volatility.


Buy This, Not That: What to Do After Nvidia’s Historic Drop

The market’s top semiconductor stock lost nearly $600 billion in market cap in a single day. But the chart tells us what we need to know.


Trump’s Memecoin: A Major Warning Sign for Crypto

When Elon Musk went on SNL to pump Dogecoin, it marked the top. Now Trump’s memecoin is sending an eerily similar signal…


Monday Takeaways: Chinese AI Rocks Markets

A new Chinese AI breakthrough sends tech stocks tumbling, just as we face a crucial week of mega-cap earnings and Fed decisions.


My No. 1 Play on Trump’s Executive Orders

New policies on trade, healthcare, and tech are creating massive sector opportunities. Here’s where to put your money now…


Dealmaker’s Diary: Data Over Drama Gives This Stock 50% Upside

While headlines focus on insurance sector challenges, one company’s fundamentals suggest a very different narrative ahead.


Buy This, Not That: Which Oil Services Company Will Win With “Drill, Baby, Drill”?

With Trump’s “drill, baby, drill” energy policy returning, here’s which oil services giant stands to benefit most.


Why “Ridiculous” Cryptos Often Deliver the Biggest Gains

While serious investors laughed at Fartcoin, early buyers made 500% returns. Understanding memecoin psychology could be key to crypto profits.


How to Turn Market Drops Into Overnight Profits

Most traders fear market drops. But a small group is using a revolutionary “Dark Ticker” strategy to target massive overnight gains when others panic.


This Hated Market Is Trading at a Huge Discount

With P/E ratios at historic lows and aggressive stimulus measures in place, China’s oversold market could be 2025’s biggest turnaround story.


BROUGHT TO YOU BY MANWARD PRESS